{"id":45564,"date":"2026-02-02T10:48:57","date_gmt":"2026-02-02T08:48:57","guid":{"rendered":"https:\/\/purama.lt\/?p=45564"},"modified":"2026-08-25T08:29:42","modified_gmt":"2026-08-25T06:29:42","slug":"nmn-vs-nr","status":"publish","type":"post","link":"https:\/\/purama.lt\/lv\/nmn-vs-nr\/","title":{"rendered":"NMN pret NR: NAD+ prekursoru sal\u012bdzin\u0101jums"},"content":{"rendered":"<p class=\"wp-block-paragraph\"><em><strong>Public\u0113ts:&nbsp;<\/strong>2026-02-02<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>NMN<\/strong> (nikot\u012bnam\u012bda mononukleot\u012bdu) un <strong>NR<\/strong> (nikot\u012bnam\u012bda ribos\u012bds) bie\u017ei vien tiek min\u0113ts vien\u0101 teikum\u0101, jo abi ir saist\u012bti ar <strong>NAD+<\/strong> Biolo\u0123ija. Tom\u0113r tas ir <strong>nav vien\u0101di<\/strong>: molekulas ir at\u0161\u0137ir\u012bgas, p\u0113tniec\u012bbas b\u0101ze ir at\u0161\u0137ir\u012bga, un pats galvenais - t\u0101 ir at\u0161\u0137ir\u012bga, <em>ko var pamatoti apgalvot.<\/em>, kad runa ir par cilv\u0113kiem, nevis hipot\u0113z\u0113m.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u0160aj\u0101 rakst\u0101 viss izkl\u0101st\u012bts vienk\u0101r\u0161i un profesion\u0101li: <strong>kas ir NAD+<\/strong>, <strong>k\u0101 NR un NMN \u201epievienojas\u201c \u0161im tematam.<\/strong>, <strong>ko r\u0101da cilv\u0113ku p\u0113t\u012bjumi<\/strong>, <strong>kur ir robe\u017eas<\/strong>, un <strong>k\u0101p\u0113c kvalit\u0101te (COA) bie\u017ei vien ir svar\u012bg\u0101ka par nosaukumu uz eti\u0137etes.<\/strong>. M\u0113r\u0137tiec\u012bgi <strong>nav pieejams<\/strong> lieto\u0161anas instrukcijas vai ieteikumus par devu.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><strong>Pla\u0161\u0101kai inform\u0101cijai:<\/strong> Lai s\u012bk\u0101k iepaz\u012btos ar NMN (zin\u0101tnes un kvalit\u0101tes krit\u0113rijiem), noklik\u0161\u0137iniet \u0161eit: <\/strong><a href=\"https:\/\/purama.lt\/lv\/nmn-celvedis\/\">Viss par NMN: piln\u012bgs ce\u013cvedis<\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">\u012ass kopsavilkums<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">\u2714\ufe0f <strong>NR<\/strong> un <strong>NMN<\/strong> - da\u017e\u0101diem NAD+ prekursoriem, kas da\u017e\u0101dos punktos \u201eiesl\u0113dzas\u201c NAD+ sint\u0113zes ce\u013c\u0101.<br>\u2714\ufe0f Redzams p\u0113t\u012bjumos ar cilv\u0113kiem <strong>NAD+ un saist\u012btie metabol\u012bti<\/strong> izmai\u0146as gan NR, gan NMN, bet <strong>biomar\u0137ieris<\/strong> nav tas pats, kas pier\u0101d\u012bts ilgtermi\u0146a kl\u012bniskais ieguvums.<br>\u2714\ufe0f Apgalvojums \u201eNMN ir tuv\u0101k NAD+, t\u0101p\u0113c ir lab\u0101ks\u201c ir <strong>ar vienk\u0101r\u0161otu<\/strong>. Biolo\u0123ij\u0101 ir svar\u012bgi transporta, audu metabolisma, stabilit\u0101tes un p\u0113t\u012bjumu pl\u0101no\u0161anas aspekti.<br>\u2714\ufe0f Praks\u0113 tas bie\u017ei vien ir <strong>Kvalit\u0101te<\/strong>COA, tre\u0161\u0101s puses anal\u012bze, t\u012br\u012bbas, piemais\u012bjumu kontrole un partijas izsekojam\u012bba.<br>\u2714\ufe0f ES kontekst\u0101 <strong>NR (nikot\u012bnam\u012bda ribos\u012bda hlor\u012bds)<\/strong> ir skaidra regul\u0113juma k\u0101rt\u012bba attiec\u012bb\u0101 uz jauniem p\u0101rtikas produktiem (ar noteiktiem nosac\u012bjumiem), un jaut\u0101jums par NMN bie\u017ei tiek apspriests k\u0101 \u201ejauna p\u0101rtikas produkta statusa\u201c jaut\u0101jums.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Kas ir NAD+ (un k\u0101p\u0113c tas ir k\u013cuvis par \u201eilgm\u016b\u017e\u012bbas\u201c t\u0113mu)?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>NAD+<\/strong> (nikot\u012bnam\u012bda aden\u012bna dinukleot\u012bds) - molekula, kas iesaist\u012bta ener\u0123ijas vielmai\u0146\u0101 un da\u017e\u0101dos \u0161\u016bnu procesos. T\u0101p\u0113c NAD+ bie\u017ei tiek piemin\u0113ts diskusij\u0101s par noveco\u0161an\u0101s biolo\u0123iju: hipot\u0113ze ir vienk\u0101r\u0161a: ja NAD+ metabolisms da\u017eos audos ar vecumu main\u0101s, tad tas var b\u016bt saist\u012bts ar vielmai\u0146as un \u0161\u016bnu izmai\u0146\u0101m.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Svar\u012bga skeptiska piez\u012bme:<\/strong> Pat ja p\u0113t\u012bjums liecina par NAD+ (vai saist\u012bto metabol\u012btu) izmai\u0146\u0101m, tas autom\u0101tiski nenoz\u012bm\u0113, ka main\u012bsies vesel\u012bbas r\u0101d\u012bt\u0101ji vai ikdienas pa\u0161saj\u016bta. Biomar\u0137ieri ir \u0161\u0101di <em>starpposma sign\u0101ls<\/em>, nevis garant\u0113ts \u201enosl\u0113gums beig\u0101s\u201c. Uzticama nov\u0113rt\u0113juma pamat\u0101 ir p\u0113t\u012bjumu pl\u0101nojums, ilgums un atk\u0101rtojam\u012bba.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Kas ir NR un kas ir NMN?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>NR<\/strong> (nikot\u012bnam\u012bda ribos\u012bds), vitam\u012bna B3 \u201esaimes\u201c savienojums, ko organisms var izmantot NAD+ sint\u0113zei, izmantojot \u012bpa\u0161us fermentu ce\u013cus.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>NMN<\/strong> (nikot\u012bnam\u012bda mononukleot\u012bds) - starpprodukts NAD+ sint\u0113zes \u0137\u0113d\u0113, bie\u017ei aprakst\u012bts k\u0101 viena no \u201epietur\u0101m\u201c ce\u013c\u0101 uz NAD+.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Izklaus\u0101s l\u012bdz\u012bgi, bet praktisk\u0101 at\u0161\u0137ir\u012bba ir t\u0101da, ka abas vielas ir \u201eNAD+ pavediens\u201c, bet t\u0101s nav identiskas - ne \u0137\u012bmiski, ne ar\u012b p\u0113c to izp\u0113tes, ne ar\u012b p\u0113c t\u0101, k\u0101 par t\u0101m run\u0101 no regulat\u012bv\u0101 viedok\u013ca.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">\u201eNR \u2192 NMN \u2192 NAD+\u201c: k\u0101p\u0113c t\u0101 ir noder\u012bga sh\u0113ma, bet ne visa aina<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Popul\u0101rajos skaidrojumos bie\u017ei atrodama vienk\u0101r\u0161ota sh\u0113ma: <strong>NR \u2192 NMN \u2192 NAD+<\/strong>. Tas pal\u012bdz saprast virzienu, bet paties\u012bb\u0101 ir svar\u012bgas v\u0113l \u010detras lietas:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Transport\u0113\u0161ana un izplat\u012b\u0161ana:<\/strong> k\u0101 savienojums nok\u013c\u016bst da\u017e\u0101dos audos un \u0161\u016bn\u0101s (organisms nav vienota \u201ecaurule\u201c).<\/li>\n\n\n\n<li><strong>Metabolisms:<\/strong> Enz\u012bmu aktivit\u0101te da\u017e\u0101dos audos at\u0161\u0137iras, t\u0101p\u0113c viens un tas pats savienojums da\u017e\u0101dos audos var \u201euzvesties\u201c at\u0161\u0137ir\u012bgi.<\/li>\n\n\n\n<li><strong>Stabilit\u0101te:<\/strong> ja materi\u0101ls no\u0101rd\u0101s vai oksid\u0113jas, teorija k\u013c\u016bst maz\u0101k svar\u012bga nek\u0101 faktisk\u0101 produkta kvalit\u0101te.<\/li>\n\n\n\n<li><strong>Ko p\u0113tnieki m\u0113ra:<\/strong> da\u017eos p\u0113t\u012bjumos m\u0113ra biomar\u0137ierus, citos - funkciju. Secin\u0101jums ir atkar\u012bgs no p\u0113t\u012bjuma m\u0113r\u0137a.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">T\u0101p\u0113c apgalvojums \u201eNMN ir tuv\u0101ks NAD+\u201c ir <strong>Hipot\u0113ze<\/strong>, nevis autom\u0101tiskas priek\u0161roc\u012bbas. Zin\u0101tnisk\u0101 atbilde parasti ir: \u201etas ir atkar\u012bgs no konteksta un no t\u0101, ko m\u0113s m\u0113ra\u201c.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Ko liecina p\u0113t\u012bjumi ar cilv\u0113kiem: biomar\u0137ieri pret re\u0101liem rezult\u0101tiem<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">\u0160eit ir v\u0113rts noteikt skaidru noteikumu: p\u0113t\u012bjumos ar cilv\u0113kiem parasti tiek mekl\u0113ti divu l\u012bme\u0146u rezult\u0101ti.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>1. l\u012bmenis - biomar\u0137ieri:<\/strong> vai NAD+ un saist\u012btie metabol\u012bti asin\u012bs vai citos paraugos ir main\u012bju\u0161ies.<\/li>\n\n\n\n<li><strong>2. l\u012bmenis - galotnes\/funkcija:<\/strong> vai ir izmai\u0146as funkcij\u0101s, labkl\u0101j\u012bb\u0101, fiziskajos vai kl\u012bniskajos parametros un vai t\u0101s ir ticami atk\u0101rtojamas.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>NR gad\u012bjums:<\/strong> Ir public\u0113ti ar placebo kontrol\u0113ti p\u0113t\u012bjumi ar cilv\u0113kiem, kuros NR palielin\u0101ja NAD+ un saist\u012bto metabol\u012btu (piem\u0113ram, NAAD u. c.) daudzumu. Piem\u0113ram, pilnu rakstu var apskat\u012bt vietn\u0113 PubMed Central (br\u012bva piek\u013cuve): <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10828186\/\" target=\"_blank\" rel=\"noreferrer noopener\">placebo kontrol\u0113ts p\u0113t\u012bjums gados vec\u0101kiem pieaugu\u0161ajiem (NR un NAD+ biomar\u0137ieri).<\/a>, k\u0101 ar\u012b pla\u0161\u0101ka NR ietekmes uz cilv\u0113kiem anal\u012bze: <a href=\"https:\/\/www.science.org\/doi\/10.1126\/sciadv.adi4862\" target=\"_blank\" rel=\"noreferrer noopener\">Science Advances p\u0101rskata raksts par NR un to, kas faktiski ir zin\u0101ms<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>NMN gad\u012bjums:<\/strong> Ir public\u0113ti ar\u012b p\u0113t\u012bjumi ar cilv\u0113kiem, kas liecina par NAD+ un metabol\u012btu izmai\u0146\u0101m. Viens no iev\u0113rojam\u0101kajiem piem\u0113riem ir <a href=\"https:\/\/www.nature.com\/articles\/s41514-022-00084-z\" target=\"_blank\" rel=\"noreferrer noopener\">placebo kontrol\u0113ts p\u0113t\u012bjums (Nature Aging)<\/a>, kas atspogu\u013co metabolomikas izmai\u0146as, tostarp ar NAD+ saist\u012btos r\u0101d\u012bt\u0101jus. Cits piem\u0113rs ir <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36482258\/\" target=\"_blank\" rel=\"noreferrer noopener\">Kl\u012bnisks p\u0113t\u012bjums (PubMed) par NMN un NAD l\u012bmeni asin\u012bs<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Svar\u012bgi ir saprast:<\/strong> biomar\u0137ieris var main\u012bties, bet tas nav tas pats, kas ilgtermi\u0146a kl\u012bniskais ieguvums. T\u0101p\u0113c nopietn\u0101 satur\u0101 vienm\u0113r tiek no\u0161\u0137irts \u201etas, ko p\u0113t\u012bjums par\u0101da\u201c, un \u201etas, ko var apsol\u012bt\u201c.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">NMN pret NR: galven\u0101s at\u0161\u0137ir\u012bbas<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Zem\u0101k ir l\u012bdz\u012bba, kur\u0101 apzin\u0101ti izlaisti \u201eapsol\u012bjumi\u201c. Vienk\u0101r\u0161i lietas, kas pal\u012bdz jums saprasties.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th class=\"has-text-align-left\" data-align=\"left\">Krit\u0113rijs<\/th><th class=\"has-text-align-left\" data-align=\"left\">NR<\/th><th class=\"has-text-align-left\" data-align=\"left\">NMN<\/th><\/tr><\/thead><tbody><tr><td><strong>P\u0113tniec\u012bbas \u201em\u0113raukla\u201c<\/strong><\/td><td>Bie\u017ei tiek apspriesti p\u0113t\u012bjumi ar NAD+ un metabol\u012btu biomar\u0137ieriem.<\/td><td>Ir veikti ar\u012b p\u0113t\u012bjumi ar cilv\u0113kiem par NAD+ metabol\u012btu izmai\u0146\u0101m; interpret\u0101cija ir atkar\u012bga no projekta un konteksta.<\/td><\/tr><tr><td><strong>\u201eArguments \u201ctuv\u0101k NAD+\"<\/strong><\/td><td>Bie\u017ei vien to raksturo k\u0101 soli ce\u013c\u0101 uz NMN\/NAD+ (vienk\u0101r\u0161oti).<\/td><td>Bie\u017ei vien tas tiek pasniegts k\u0101 \u201etuv\u0101ks\u201c, ta\u010du bez datiem par stabilit\u0101ti un izplat\u012bbu tas nav rakstur\u012bga priek\u0161roc\u012bba.<\/td><\/tr><tr><td><strong>Normat\u012bvais konteksts (ES)<\/strong><\/td><td>NR hlor\u012bds ir at\u013cauts k\u0101 \u201ejauns p\u0101rtikas produkts\u201c ar nosac\u012bjumiem (skat\u012bt ofici\u0101los dokumentus).<\/td><td>NMN bie\u017ei d\u0113v\u0113 par \u201ejauna p\u0101rtikas produkta statusa\u201c jaut\u0101jumu; ir v\u0113rts atsaukties uz ofici\u0101lajiem statusa avotiem.<\/td><\/tr><tr><td><strong>Kvalit\u0101te\/p\u0101rredzam\u012bba<\/strong><\/td><td>Svar\u012bga ir skaidra forma (piem\u0113ram, \u201eNR hlor\u012bds\u201c) un COA ar partijas numuru.<\/td><td>\u013boti svar\u012bga ir stabilit\u0101te, piemais\u012bjumu kontrole, COA un izsekojam\u012bba.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Galven\u0101 zi\u0146a:<\/strong> bie\u017ei vien at\u0161\u0137ir\u012bba \u201epat\u0113r\u0113t\u0101ja pus\u0113\u201c ir ne tikai molekula, bet ar\u012b tas, vai produkts ir <strong>ko var p\u0101rbaud\u012bt ar dokumentiem<\/strong> un vai inform\u0101cija nav tikai m\u0101rketings.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Kvalit\u0101te: k\u0101 izprast COA (anal\u012bzes sertifik\u0101tu) bez \u0137\u012bmijas diploma<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">COA nav \u201eskaists PDF dokuments\u201c. Labs COA atbild uz vienk\u0101r\u0161u jaut\u0101jumu: <strong>vai \u0161ai konkr\u0113tajai partijai patie\u0161\u0101m ir tas, ko t\u0101 apgalvo, ka tai ir.<\/strong>, un vai ir k\u0101das ac\u012bmredzamas kvalit\u0101tes probl\u0113mas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Kas ir patiesi v\u0113rt\u012bgs COA dokument\u0101:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>T\u012br\u012bba (%)<\/strong> - skaidru skaitli. Augstas t\u012br\u012bbas pak\u0101pes teksts bez skait\u013ciem ir v\u0101j\u0161 arguments.<\/li>\n\n\n\n<li><strong>Puses numurs<\/strong> - COA j\u0101b\u016bt saist\u012btam ar konkr\u0113tu partiju (lai dokuments neb\u016btu \u201evisp\u0101r\u012bgs\u201c).<\/li>\n\n\n\n<li><strong>Piemais\u012bjumi\/ pies\u0101r\u0146ot\u0101ji<\/strong> - vismaz pamatkontroles p\u0113c produktu veida (\u0161eit svar\u012bga ir metodolo\u0123ija un skaidr\u012bba).<\/li>\n\n\n\n<li><strong>Kas veica anal\u012bzi<\/strong> - laboratorijas identifik\u0101cija, metode vai vismaz skaidrs laboratorijas \u201enospiedums\u201c.<\/li>\n\n\n\n<li><strong>Datums un izsekojam\u012bba<\/strong> - dokumentam j\u0101b\u016bt reproduc\u0113jamam, nevis tikai m\u0101rketinga papildin\u0101jumam.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>K\u0101p\u0113c tas ir svar\u012bgi NAD+ t\u0113mai:<\/strong> tirgus ir pilns ar lieliem sol\u012bjumiem. COA un izsekojam\u012bba \u013cauj mums pa\u013cauties uz p\u0101rbaud\u0101miem faktiem, nevis tikai uz emocion\u0101lu st\u0101st\u012bjumu.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Normat\u012bvais aspekts: kur ofici\u0101li mekl\u0113t (ja v\u0113laties ieg\u016bt faktus)<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Ja v\u0113laties pa\u013cauties uz dokumentiem, nevis interpret\u0101cij\u0101m, \u0161ie ofici\u0101lie avoti ir noder\u012bgi:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX%3A32022R1160\" target=\"_blank\" rel=\"noreferrer noopener\">EUR-Lex: Komisijas \u012bsteno\u0161anas regula par nikot\u012bnam\u012bda ribos\u012bda hlor\u012bdu k\u0101 jaunu p\u0101rtikas produktu\u201e<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/efsa.onlinelibrary.wiley.com\/doi\/10.2903\/j.efsa.2021.6843\" target=\"_blank\" rel=\"noreferrer noopener\">EFSA zin\u0101tniskais atzinums: Nikot\u012bnam\u012bda ribos\u012bda hlor\u012bda lieto\u0161anas termi\u0146a pagarin\u0101\u0161ana<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/food.ec.europa.eu\/food-safety\/novel-food\/consultation-process-novel-food-status_en\" target=\"_blank\" rel=\"noreferrer noopener\">Eiropas Komisija: apsprie\u0161an\u0101s par jauno p\u0101rtikas produktu statusu (tostarp NMN statusa dokumenti)<\/a><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">\u0160\u012b rindkopa papildina rakstu ar div\u0101m liet\u0101m: <strong>uztic\u0113\u0161an\u0101s<\/strong> un <strong>skaidra at\u0161\u0137ir\u012bba<\/strong> starp zin\u0101tniskaj\u0101m debat\u0113m un normat\u012bvo realit\u0101ti.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">NR produkti veikal\u0101 Purama<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Ja j\u016bs interes\u0113 <strong>NR<\/strong> Lai uzzin\u0101tu vair\u0101k par virzieniem, \u0161eit ir divas izv\u0113les iesp\u0113jas no Purama kl\u0101sta. \u0160is raksts apzin\u0101ti <strong>lieto\u0161ana, uz ko neattiecas<\/strong> - tikai informat\u012bvas atsauces uz produkta specifik\u0101cij\u0101m. <\/p>\n\n\n\n<h3 class=\"wp-block-heading\">T\u012bra NR (nikot\u012bnam\u012bda ribos\u012bda hlor\u012bds) - DoNotAge<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">NR forma (hlor\u012bds) un uzsvars uz p\u0101rredzam\u012bbu ir skaidri identific\u0113ti. S\u012bk\u0101ka inform\u0101cija, dokument\u0101cija un specifik\u0101cija produkta lap\u0101.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/purama.lt\/lv\/products\/donotage-pure-nr-kapsulas\/\">Apskat\u012bt produktu<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ir pieejams pilns DoNotAge kl\u0101sts - no NAD+ prekursoriem l\u012bdz senol\u012btiskiem l\u012bdzek\u013ciem un miega formul\u0101m. <a href=\"https:\/\/purama.lt\/lv\/produktu-etiketes\/donotage\/\">Z\u012bmola DoNotAge lap\u0101<\/a>. Visi produkti ar COA dokument\u0101ciju un partijas izsekojam\u012bbu.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">L-Cell NR pulveris - 24 g<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Pulvera form\u0101ts ar skaidr\u0101m specifik\u0101cij\u0101m. S\u012bk\u0101ka inform\u0101cija un produkta apraksts atrodams produkta lap\u0101.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/purama.lt\/lv\/products\/l-sunu-nr-pulveris-24g\/\">Apskat\u012bt produktu<\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Bie\u017e\u0101k uzdotie jaut\u0101jumi (6 jaut\u0101jumi)<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">1) Vai NMN un NR ir tas pats?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">N\u0113. Abi ir NAD+ prekursori, bet tie ir da\u017e\u0101di savienojumi un da\u017e\u0101das \u0137\u0113des da\u013cas.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">2) Vai \u201eNMN tuv\u0101k NAD+\u201c noz\u012bm\u0113, ka tas ir lab\u0101ks?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Ne vienm\u0113r. \u201eTuv\u0101k\u201c ir teor\u0113tisks arguments. Praks\u0113 svar\u012bga ir stabilit\u0101te, audu sadal\u012bjums, vielmai\u0146a un testu rezult\u0101ti cilv\u0113kiem.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">3) Ko visbie\u017e\u0101k par\u0101da p\u0113t\u012bjumi ar cilv\u0113kiem: biomar\u0137ierus vai faktiskos rezult\u0101tus?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Biomar\u0137ieru (NAD+ un metabol\u012btu) izmai\u0146as bie\u017ei vien tiek re\u0123istr\u0113tas pirm\u0101s. Funkcion\u0101lajiem un ilgtermi\u0146a kl\u012bniskajiem rezult\u0101tiem nepiecie\u0161ami ilg\u0101ki un r\u016bp\u012bg\u0101ki p\u0113t\u012bjumi.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">4) K\u0101p\u0113c COA ir tik svar\u012bga?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Jo \u0161\u012b ni\u0161a ir m\u0101rketinga magn\u0113ts. COA, partijas numurs un tre\u0161o pu\u0161u anal\u012bzes \u013cauj mums pa\u013cauties uz p\u0101rbaud\u0101miem faktiem.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">5) Kur es varu atrast ofici\u0101lu dokument\u0101ciju par regulat\u012bvo statusu?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Visdro\u0161\u0101kie avoti ir EUR-Lex (ES regulas), EFSA zin\u0101tniskie atzinumi un Eiropas Komisijas konsult\u0101ciju lapa par jauno p\u0101rtikas produktu statusu (saites iepriek\u0161).<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">6) Kur atrast pla\u0161\u0101ku NMN kontekstu?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">S\u012bk\u0101ku skaidrojumu par NMN, tirgus realit\u0101ti, p\u0113tniec\u012bbas lo\u0123iku un kvalit\u0101tes krit\u0113rijiem skat\u012bt galvenaj\u0101 rakst\u0101: <a href=\"https:\/\/purama.lt\/lv\/nmn-celvedis\/\">Viss par NMN: piln\u012bgs ce\u013cvedis<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Publikuota:&nbsp;2026-02-02 NMN (nikotinamido mononukleotidas) ir NR (nikotinamido ribosidas) da\u017enai minimi viename sakinyje, nes abu siejami su NAD+ biologija. Visgi tai n\u0117ra tas pats: skiriasi molekul\u0117s, skiriasi tyrim\u0173 baz\u0117, o svarbiausia \u2013 skiriasi tai, k\u0105 realiai galima pagr\u012fstai teigti, kai kalbame apie \u017emones, o ne apie hipotezes. \u0160iame straipsnyje viskas i\u0161d\u0117styta paprastai ir profesionaliai: kas yra [&hellip;]<\/p>\n","protected":false},"author":38,"featured_media":45574,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[310],"tags":[],"class_list":["post-45564","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ilgaamziskumo-gidas"],"acf":[],"_links":{"self":[{"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/posts\/45564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/comments?post=45564"}],"version-history":[{"count":0,"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/posts\/45564\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/media\/45574"}],"wp:attachment":[{"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/media?parent=45564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/categories?post=45564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/purama.lt\/lv\/wp-json\/wp\/v2\/tags?post=45564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}